Friday, 25 May 2018

You are here

The RheumNow Week in Review – Why Comorbidity is Like the Weather (5.3.18)

Dr. Jack Cush discusses the news and journal articles from the past week on RheumNow.com.

  1. Sandoz biosimilar version of rituximab set back by a complete response letter from the FDA delaying development of their RTX biosimilar; same recent fate as Celltrions RTX biosimilar. https://t.co/EkikDMU1u8
  2. April meeting of European Medicines Agency, the Committee for Medicinal Products for Human Use (CHMP) recommended the approval of new indications for CIMZIA- certolizumab pegol (for plaque psoriasis) and XELJANZ-tofacitinib (for psoriatic arthritis). https://t.co/W4A0AIyZ80
  3. Creaky Joints and GHLF survey shows New York patients with chronic health conditions have experienced “non-medical switching” (with unsavory consequences) —insurance coverage reductions which pressure patients to switch their prescription medication; https://t.co/t8z7iXVjqW
  4. JAMA Neurology, reports IBD patients have ~30% higher risk of Parkinsons; But early treatment with an anti-TNF gave an almost 80% reduction in parkinsons in those with IBD. https://t.co/YmVUjREyo7
  5. Diffuse scleroderma and who are positive for RNA polymerase III autoantibodies (antipol), have a 3 yr risk of cancer that is notably high, SIR=3.13 (95% CI 2.03-4.62, P<0.001) https://t.co/7xbtqCXQq1 
  6. CDC study of USA death Certificates, between 2000-2015, there were 28,411 female deaths with SLE. SLE in top 20 causes of adult female deaths. For females, SLE ranked 10th for 15-24 yrs; 14th for 25-34 yrs; 14th for 35-44 yrs and 15th for 10-14 yrs. https://t.co/JkLxdrnf1z
  7. Genetic Breakthrough in Systemic JIA  
  8. Severe Obesity Worsens Disability in Rheumatoid Arthritis  
  9. Comorbidities Undermine Clinical Outcomes in Psoriatic Arthritis  

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

The RheumNow Week in Review – Methotrexate CIRT Study (5.25.18)

Dr. Jack Cush reviews this past weeks news from RheumNow.com - the risk of Cutaneous and Systemic LE, increasing flu vaccination, higher risk of VTE, MPO predictions, new drug for GIOP and CIRT - MTX in cardiovascular risk patients.

ACR Leaders Lobby Capitol Hill for Help on Rising Costs and Access Barriers in Arthritis Care

Rheumatologists and rheumatology health professionals convened on Capitol Hill this week to urge legislative action on pressing policy issues affecting rheumatology care during the American College of Rheumatology’s Advocacy Leadership Conference, held May 16 -17, 2018 in Washington, D.C.

The RheumNow Week in Review – Modifiable Behavior (5.18.18)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  He discusses opioids, new approval for polyarticular JIA, running and osteoarthritis, and modifiable behaviors that influence outcomes. 

The RheumNow Week in Review - Nonadherence and Astronomic Costs (5.11.18)

Dr. Jack Cush reviews highlights, news and journal articles from the past week on RheumNow.com.

Rising Need for Weight Loss Counseling in Arthritic Patients

The CDC's May 4th MMWR reports that from 2002 to 2014, the prevalence of health care provider counseling for weight loss among adults with arthritis and overweight or obesity increased by 10% (from 35% to 45%).

Among the 54.4 million adults with doctor-diagnosed arthritis in the United States, 32.7% are overweight and 38.1% are obese. Moreover obesity is more prevalent among persons with arthritis than among those who do not have arthritis.